The subject of the final panel in the BPI Theater at BIO was how single-use technologies are enabling companies to meet the demand for commercial biomanufacturing capacity. Over the past decade, the industry has been adopting
disposable bioreactors and other bioprocessing equipment for clinical
manufacturing of biopharmaceuticals. Moderator Dan Stanton began this discussion by asking panelists where the industry stands currently for single-use technologies in
making commercial products.

Along with Stanton, the roundtable discussion features John Godshalk (senior consultant, Biologics Consulting Group), Gene Yoshioka (director of manufacturing, Avid BioServices), Steven Hager (senior director of technical support, Catalent Biologics), Shiva Khalafpour (head of commercial, clinical development and manufacturing, Lonza Pharma & Biotech), and Jie Chen (vice president of chemistry, manufacturing, and controls, Wu Xi Biologics.

Watch the full roundtable discussion below and leave your thoughts or questions on the topic below in the comments.